Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 4/20 | 0.53 |
| ▸ | LAP3 | P28838 | 2/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.46 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.46 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.46 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.46 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11218189 | 0.80 | SPHK1 (0.56) | FDPSSPHK1 | |
| SCHEMBL9240010 | 0.79 | LAP3 (0.59) | FDPSLAP3PTPN1S1PR2S1PR1 | |
| SCHEMBL2385582 | 0.76 | SPHK1 (0.62) | SPHK1 | |
| SCHEMBL3344513 | 0.76 | SPHK1 (0.62) | SPHK1 | |
| SCHEMBL13825654 | 0.76 | SPHK1 (0.62) | SPHK1 | |
| SCHEMBL10607850 | 0.76 | SPHK1 (0.62) | SPHK1 | |
| SCHEMBL136612 | 0.76 | SPHK1 (0.62) | SPHK1 | |
| SCHEMBL7756046 | 0.76 | SPHK1 (0.62) | SPHK1 | |
| SCHEMBL10605211 | 0.76 | SPHK1 (0.62) | SPHK1 | |
| SCHEMBL27963355 | 0.76 | SPHK1 (0.62) | SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120172631-A1 | PHOSPHATIDYL OLIGOGLYCEROLS | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E. V. (DE) | 2012-07-05 | — | — | US | disclosed |
| US-8076520-B2 | Phosphatidyl oligoglycerols | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2011-12-13 | — | — | US | disclosed |
| US-20100280282-A1 | PHOSPHATIDYL OLIGOGLYCEROLS | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2010-11-04 | — | — | US | disclosed |
| US-7709464-B2 | Phosphatidyl oligoglycerols | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E. V. (DE) | 2010-05-04 | — | — | US | disclosed |
| US-20090035358-A1 | PHOSPHATIDYL OLIGOGLYCEROLS | MAX-PLANCK-GESSELSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2009-02-05 | — | — | US | disclosed |
| US-7351428-B2 | Phosphatidyl oligoglycerols | MAX-PLANCK-GESSELSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2008-04-01 | — | — | US | disclosed |
| US-6413543-B1 | DRUG DELIVERY | MAX-PLANCK-GESSELSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2002-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100280282-A1 | PHOSPHATIDYL OLIGOGLYCEROLS | PHOSPHO1, SGMS2, LIPG | FDPS 1510/4885LAP3 1299/4885PTPN1 2213/4885 |
| US-20120172631-A1 | PHOSPHATIDYL OLIGOGLYCEROLS | PHOSPHO1, SGMS2, LIPG | FDPS 1510/4885LAP3 1299/4885PTPN1 2213/4885 |
| US-20090035358-A1 | PHOSPHATIDYL OLIGOGLYCEROLS | PHOSPHO1, SGMS2, LIPG | FDPS 1510/4885LAP3 1299/4885PTPN1 2213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.